全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.1-2Wiley
摘要:No abstract is available for this article.
作者:Alexander D. Heini , Rebecca Hugo , Martin D. Berger ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.74-81Wiley
摘要:Abstract(#br)High levels of acute phase reactants can be associated with adverse outcome in patients with various solid tumor types. For patients with acute myeloid leukemia (AML), this correlation is unknown. We retrospectively investigated the prognostic value of pretreatm...
作者:Carolina Simioni , Fabio Bergamini , Martina Ferioli ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.22-33Wiley
摘要:Abstract(#br)Acute lymphoblastic leukemia (ALL) represents a heterogeneous group of hematologic malignancies, and it is normally characterized by an aberrant proliferation of immature lymphoid cells. Moreover, dysregulation of multiple signaling pathways that normally regula...
作者:Borahm Kim , Esl Kim , Seung‐Tae Lee ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.82-88Wiley
摘要:Abstract(#br)Identification of gene fusion is an essential part in the management of patients with acute leukemia, not only for diagnosis but also in predicting the treatment outcome and selecting appropriate treatment. Adopting next‐generation sequencing (NGS) technology fo...
作者:Johanne Marie Holst , Maja Ludvigsen , Stephen Jacques Hamilton‐Dutoit ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.59-66Wiley
摘要:Abstract(#br)Galectin‐1 (Gal‐1) has been associated with adverse prognosis in several cancers including lymphoma entities with CD30 expression. However, Gal‐1 expression has not been systematically assessed in peripheral T‐cell lymphomas (PTCL). Specimens from 169 nodal...
作者:Daria Gaut , Tahmineh Romero , David Oveisi ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.38-50Wiley
摘要:Abstract(#br)While various tools such as the International Prognostic Index (IPI) and its derivatives exist for risk‐stratification of diffuse large B‐cell lymphoma (DLBCL) at diagnosis, patient and disease characteristics capable of predicting outcome after high‐dose c...
作者:Irina V. Poddubnaya , Sergey M. Alekseev , Kamil D. Kaplanov ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.67-73Wiley
摘要:Abstract(#br)BCD‐020 is a proposed rituximab biosimilar, which has shown high similarity to rituximab in quality and nonclinical studies in vitro and in vivo.(#br)International multicenter clinical trial was conducted to compare efficacy and safety of BCD‐020 and reference r...
作者:Francesco Piazza , Sabrina Manni , Arash Arjomand ...
来源:[J].Hematological Oncology(IF 2.036), 2020, Vol.38 (1), pp.3-11Wiley
摘要:Abstract(#br)The knowledge accumulated over the last decade on B‐cell–derived non‐Hodgkin lymphoma (B‐NHL) pathogenesis has led to the identification of several molecular abnormalities, opening new perspectives in the design of novel therapies. Indeed, drugs targeting s...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×